[Results of controlled continuous observation during prolonged oral treatment with Persantin].
D000284:Administration, Oral; D003327:Coronary Disease; D004176:Dipyridamole; D006801:Humans
D004176:Dipyridamole
CORONARY DISEASE; PERSANTIN